Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | Director | February 03, 2026 | February 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 47,150 |
Reported balance
After 2026-02-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 3,908 · Balance 47,150 F1: Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2: Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
F2: Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2026 Filed Feb 5, 2026 19:52 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-039913 · ownership.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,150 F1 · acquired: Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 19:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015656 · ownership.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,242 F1 · acquired: Award represents a total of 3,140 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2026 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,140 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012861 · ownership.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,102 F1 · acquired: Award represents a total of 2,952 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2025 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,500 | $84.53 | $211,318.50 |
DisclosureSEC source: 0001209191-23-010326 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,150 F1 · price: This transaction was executed in multiple trades at prices ranging from $84.49 to $84.601. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008216 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,650 F1 · acquired: Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 20:36 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-008258 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,354 F1 · acquired: Award represents a total of 2,783 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2023 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 18:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007881 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,571 F1 · acquired: Award represents a total of 2,661 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2022 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,661 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 16:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftClass A Common Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-060513 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,910 F1 · kind: Gift to charitable and/or non-profit organization. F2 · balance_after: Shares held following the reported transactions include 3,627 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 17:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007263 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,110 F1 · acquired: Award represents a total of 3,627 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2021 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,627 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 18:16 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007860 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,483 F1 · acquired: Award represents a total of 3,996 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2020 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,996 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 20:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008624 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,487 F1 · acquired: Award represents a total of 3,920 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2019 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,920 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 17:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 5,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009149 · doc4.xml · nonDerivative · entry 1 Segars Simon · CIK 0001632353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,567 F1 · acquired: Award represents a total of 5,233 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2018 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 5,233 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.